Travere Therapeutics
TVTX
#3215
Rank
NZ$8.29 B
Marketcap
NZ$89.18
Share price
6.40%
Change (1 day)
271.42%
Change (1 year)

Market capitalization of Travere Therapeutics (TVTX)

Market cap: NZ$8.29 Billion

As of June 2026 Travere Therapeutics has a market cap of NZ$8.29 Billion. This makes Travere Therapeutics the world's 3215th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Travere Therapeutics from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$8.29 B35.42%
2025NZ$6.12 B129.64%
2024NZ$2.66 B149.63%
2023NZ$1.06 B-49.74%
2022NZ$2.12 B-23.6%
2021NZ$2.78 B40.98%
2020NZ$1.97 B117.23%
2019NZ$0.90 B-34.94%
2018NZ$1.39 B19.74%
2017NZ$1.16 B13.09%
2016NZ$1.03 B0.33%
2015NZ$1.02 B152.57%
2014NZ$0.40 B159.41%
2013NZ$0.15 B330.27%
2012NZ$36.45 M29566.83%
2011NZ$0.12 M

End of Day market cap according to different sources

On Jun 13th, 2026 the market cap of Travere Therapeutics was reported to be:

NZ$8.29 Billion
by Nasdaq info icon info icon
NZ$8.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
NZ$1.83 B-77.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$35.82 M-99.57%๐Ÿ‡บ๐Ÿ‡ธ USA